Proterra’s Statement on Minimal Exposure to Silicon Valley Bank: A Heartfelt Perspective

Proterra’s Statement on Minimal Exposure to Silicon Valley Bank: A Heartfelt Perspective BURLINGAME, Calif., March 12, 2023 (GLOBE NEWSWIRE) — Proterra Inc (NASDAQ: PTRA), a leading innovator in commercial vehicle electrification technology, today issued the following statement regarding Silicon Valley Bank’s (“SVB”) transition into receivership by the Federal Deposit Insurance Corporation (“FDIC”): “While we continue…

Read More

Attention Catalent Inc. Investors: Don’t Miss the Deadline for Securities Class Action – Rosen, a Leading Law Firm, Urges You to Seek Counsel Now!

Investor Rights Law Firm Reminds Catalent, Inc. Investors of Important Deadline Introduction: In a recent announcement, Rosen Law Firm, a leading global investor rights law firm, has reminded purchasers of Catalent, Inc. securities about an upcoming deadline. Investors who acquired securities of Catalent, Inc. between August 30, 2021 and October 31, 2022, are urged to…

Read More

Breaking News: Ventyx Biosciences Spills the Tea on Silicon Valley Bank’s Financial Exposure!

Welcome to Ventyx Biosciences Update! What’s the Buzz About Silicon Valley Bank? Hey there, fellow finance enthusiasts! If you haven’t heard the latest news, Silicon Valley Bank has been shut down by the California Department of Financial Protection and Innovation. That’s right, the FDIC is stepping in as receiver. So, what does this mean for…

Read More

Attention Bioventus Inc. Investors: Don’t Miss the March 13th Deadline for Securities Class Action – A Call to Secure Counsel from Leading Law Firm Rosen

Attention Bioventus Inc. Investors: Don’t Miss the March 13th Deadline for Securities Class Action New York- March 11, 2023- Globe Newswire Reminder for Bioventus Inc. Investors Rosen Law Firm, a prominent global investor rights law firm, is issuing a crucial reminder to all investors who have purchased stock in Bioventus Inc. (NASDAQ: BVS). This reminder…

Read More

Immix Biopharma: No Exposure to Silicon Valley Bank or Silvergate Bank Confirmed – A Heartfelt Update

Immix Biopharma: No Exposure to Silicon Valley Bank or Silvergate Bank Confirmed – A Heartfelt Update LOS ANGELES, March 10, 2023 Immix Biopharma, Inc. (Nasdaq: IMMX), also known as ImmixBio, is a leading biopharmaceutical company that specializes in Tissue-Specific Therapeutics (TSTx)™ targeting oncology and immuno-dysregulated diseases. In a recent update, the company has confirmed that…

Read More

Uncovering Investor Claims: Pomerantz Law Firm Investigates Nutanix Inc. (NTNX)

Breaking News: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Nutanix, Inc. MARCH 10, 2023 SHAREHOLDER ALERT New York – Pomerantz LLP is currently conducting an investigation on behalf of investors of Nutanix, Inc. (NASDAQ: NTNX). Investors who have shares in Nutanix are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529,…

Read More